Search clinical trials for: neutralizing antibody

Total 5313 results

Roger Williams Medical Center
National Cancer Institute (NCI); Beth Israel Deaconess Medical Center

Completed

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Lymphoma | Leukemia

United States
Stanford University
National Institutes of Health (NIH); Amgen

Completed

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment

Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditions

United States
ESBATech AG

Completed

Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis

Anterior Uveitis

Germany
Centocor Ortho Biotech Services, L.L.C.

Completed

Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

Rheumatoid Arthritis
Centocor, Inc.

Completed

A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD

Chronic Obstructive Pulmonary Disease | COPD
McGill University Health Centre/Research Institute...
McGill University

Terminated

Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)

Complex Regional Pain Syndromes

Canada
Neovii Biotech
Fresenius Biotech North America

Terminated

Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy

Advanced Breast Cancer | Metastatic Breast Cancer

United States, Canada
Abbott

Completed

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis (ATLAS)

Ankylosing Spondylitis

United States
Seoul National University Hospital
Seoul National University Boramae Hospital

Completed

The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td

Tetanus
Mayo Clinic
Roche Pharma AG

Completed

CellCept in p-ANCA Vasculitis

Microscopic Polyangiitis | MPO-ANCA Vasculitis

United States
Centre René Gauducheau

Completed

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 (BB4)

Multiple Myeloma

France
National Institute of Allergy and Infectious Diseases...

Completed

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

HIV Infections

United States, Australia
Peregrine Pharmaceuticals

Completed

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Tumors

United States
Functional Genetics Inc.
United States Department of Defense

Unknown

Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)

Influenza

United States
Bradmer Pharmaceuticals Inc.

Terminated

Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy (Glass-Art)

Glioblastoma Multiforme
Northwestern University
National Cancer Institute (NCI)

Completed

Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results

Cervical Cancer

United States
St. Joseph's Healthcare Hamilton
GlaxoSmithKline

Completed

The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)

Asthma

Canada
Johann Wolfgang Goethe University Hospital

Completed

Generation of Standard Laboratory Values for Pneumococci Antibodies

Reference Values

Germany
Probiomed S.A. de C.V.

Unknown

TREatment of degeNerative and Neoplastic Diseases With Rituximab (TREND)

Diffuse Large B Cell Lymphoma

Mexico
Biogen

Terminated

Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's

United States
Mayo Clinic
Genzyme, a Sanofi Company

Completed

A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.

Kidney Transplant

United States
Sahlgrenska University Hospital, Sweden

Unknown

Antibody Levels Against 2009 Influenza A H1N1 One Year After Vaccination With Pandemrix and 2010 Fluarix Booster in Organ Transplant Recipients.

Organ Transplantation

Sweden
Hillel Yaffe Medical Center

Unknown

Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized Patients

ANCA-related Vasculitis

Israel
University of Padova

Unknown

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy (ELIDACE)

Moderate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.

Italy
Sanofi

Completed

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Multiple Myeloma

France, Italy
PanGenetics UK Limited

Terminated

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

Serbia
Centocor, Inc.

Completed

A Study Evaluating Intravenous and Subcutaneous Administration of a Human Monoclonal Antibody (CNTO 5825) in Healthy Volunteers

Healthy
Nantes University Hospital

Completed

Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects (Oberab)

Gastroesophageal Reflux

France
ESBATech AG

Completed

Ocular Biodistribution Study for Topically Applied ESBA105

Cataract

Switzerland
ESBATech AG

Completed

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

Osteoarthritis

Germany, Switzerland
Michael E. DeBakey VA Medical Center
Baylor College of Medicine

Completed

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

Clostridium Enterocolitis | Pseudomembranous Colitis | Antibiotic-Associated Colitis

United States
Public Health England

Completed

A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza (Snuffles)

H1N1 Virus
National Institute of Allergy and Infectious Diseases...

Completed

Monoclonal Antibody for Treatment of Inhalation Anthrax

Bacillus Anthracis (Anthrax)

United States
Biogen

Terminated

Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma

Colorectal Cancer | Metastases

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia

Leukemia

United States
Sanofi

Terminated

Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma

Liver Carcinoma

France
Peking University People's Hospital

Unknown

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Rabies

China
MedImmune LLC

Completed

BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
Silesian School of Medicine
Ministry of Science and Higher Education, Poland

Completed

Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes (JACK-EPC)

Coronary Heart Disease | Acute Coronary Syndromes

Poland
National Institute of Neurological Disorders and...

Completed

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Myositis, Inclusion Body

United States
Nanjing University School of Medicine

Completed

MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis

Vasculitis | Anti-Neutrophil Cytoplasmic Antibody

China
Kaplan Medical Center
Gilead Sciences

Unknown

The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

Israel
Centocor, Inc.

Completed

A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian Volunteers

Healthy
Bristol-Myers Squibb

Completed

Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA) (MDX1100-04)

Rheumatoid Arthritis

Romania, Ukraine
Bristol-Myers Squibb

Completed

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Ulcerative Colitis

United States
University of Washington
Hoffmann-La Roche

Completed

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Diabetic Nephropathies | Kidney Failure, Chronic | Glomerulonephritis, IGA | Hypertension, Renal

United States
Chinese Academy of Sciences
Jiangsu Province Centers for Disease Control and Prevention; Hualan Biological...

Unknown

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

Human Influenza

China
Eli Lilly and Company
University of Colorado, Denver; Indiana University; Greenwich Hospital

Completed

Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center; Merck KGaA, Darmstadt, Germany; US Department... and other collaborators

Completed

Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

Carcinoma, Small Cell Lung
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

Leukemia

United States

3

Subscribe